{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:11:40Z","timestamp":1790633500211,"version":"4.1.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,11,9]],"date-time":"2012-11-09T00:00:00Z","timestamp":1352419200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00401-012-1065-6","type":"journal-article","created":{"date-parts":[[2012,11,8]],"date-time":"2012-11-08T04:54:09Z","timestamp":1352350449000},"page":"187-199","source":"Crossref","is-referenced-by-count":63,"title":["Presenilin-1 adopts pathogenic conformation in normal aging and in sporadic Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"125","author":[{"given":"Lara","family":"Wahlster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Arimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navine","family":"Nasser-Ghodsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn Leigh","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Serrano-Pozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Berezovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,9]]},"reference":[{"issue":"4","key":"1065_CR1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0896-6273(01)00512-8","volume":"32","author":"WG Annaert","year":"2001","unstructured":"Annaert WG, Esselens C, Baert V et al (2001) Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins. Neuron 32(4):579\u2013589","journal-title":"Neuron"},{"issue":"9","key":"1065_CR2","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1212\/WNL.42.9.1681","volume":"42","author":"PV Arriagada","year":"1992","unstructured":"Arriagada PV, Marzloff K, Hyman BT (1992) Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer\u2019s disease. Neurology 42(9):1681\u20131688","journal-title":"Neurology"},{"issue":"2","key":"1065_CR3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0169-328X(99)00119-9","volume":"69","author":"O Berezovska","year":"1999","unstructured":"Berezovska O, Frosch M, McLean P et al (1999) The Alzheimer-related gene presenilin 1 facilitates notch 1 in primary mammalian neurons. Brain Res Mol Brain Res 69(2):273\u2013280","journal-title":"Brain Res Mol Brain Res"},{"issue":"11","key":"1065_CR4","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1523\/JNEUROSCI.0364-05.2005","volume":"25","author":"O Berezovska","year":"2005","unstructured":"Berezovska O, Lleo A, Herl LD et al (2005) Familial Alzheimer\u2019s disease presenilin 1 mutations cause alterations in the conformation of presenilin and interactions with amyloid precursor protein. J Neurosci 25(11):3009\u20133017","journal-title":"J Neurosci"},{"issue":"5","key":"1065_CR5","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0896-6273(00)80230-5","volume":"17","author":"DR Borchelt","year":"1996","unstructured":"Borchelt DR, Thinakaran G, Eckman CB et al (1996) Familial Alzheimer\u2019s disease-linked presenilin 1 variants elevate Abeta1-42\/1-40 ratio in vitro and in vivo. Neuron 17(5):1005\u20131013","journal-title":"Neuron"},{"issue":"11","key":"1065_CR6","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/nn.2660","volume":"13","author":"DA Bosco","year":"2010","unstructured":"Bosco DA, Morfini G, Karabacak NM et al (2010) Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nature Neurosci 13(11):1396\u20131403","journal-title":"Nature Neurosci"},{"issue":"4","key":"1065_CR7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropath 82(4):239\u2013259","journal-title":"Acta Neuropath"},{"issue":"3","key":"1065_CR8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1385\/MN:27:3:325","volume":"27","author":"GC Brown","year":"2003","unstructured":"Brown GC, Bal-Price A (2003) Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol 27(3):325\u2013355","journal-title":"Mol Neurobiol"},{"issue":"11","key":"1065_CR9","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1532-5415.1993.tb07306.x","volume":"41","author":"WJ Burke","year":"1993","unstructured":"Burke WJ, Roccaforte WH, Wengel SP et al (1993) L-deprenyl in the treatment of mild dementia of the Alzheimer type: results of a 15-month trial. J Am Geriatr Soc 41(11):1219\u20131225","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"1065_CR10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/10715762.2010.520014","volume":"45","author":"DA Butterfield","year":"2011","unstructured":"Butterfield DA, Reed T, Sultana R (2011) Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer\u2019s disease. Free Radical Res 45(1):59\u201372","journal-title":"Free Radical Res"},{"issue":"1","key":"1065_CR11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nm0197-67","volume":"3","author":"M Citron","year":"1997","unstructured":"Citron M, Westaway D, Xia W et al (1997) Mutant presenilins of Alzheimer\u2019s disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nature Med 3(1):67\u201372","journal-title":"Nature Med"},{"issue":"7","key":"1065_CR12","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.0305799101","volume":"101","author":"RG Cutler","year":"2004","unstructured":"Cutler RG, Kelly J, Storie K et al (2004) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer\u2019s disease. Proc Natl Acad Sci USA 101(7):2070\u20132075","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6665","key":"1065_CR13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/34910","volume":"391","author":"B Strooper De","year":"1998","unstructured":"De Strooper B, Saftig P, Craessaerts K et al (1998) Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391(6665):387\u2013390","journal-title":"Nature"},{"issue":"2","key":"1065_CR14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrneurol.2009.218","volume":"6","author":"B Strooper De","year":"2010","unstructured":"De Strooper B, Vassar R, Golde T (2010) The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat Rev Neurol 6(2):99\u2013107","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"1065_CR15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ana.410270502","volume":"27","author":"ST DeKosky","year":"1990","unstructured":"DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer\u2019s disease: correlation with cognitive severity. Ann Neurol 27(5):457\u2013464","journal-title":"Ann Neurol"},{"issue":"6809","key":"1065_CR16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/35041687","volume":"408","author":"T Finkel","year":"2000","unstructured":"Finkel T, Holbrook NJ (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408(6809):239\u2013247","journal-title":"Nature"},{"key":"1065_CR17","doi-asserted-by":"crossref","unstructured":"Galasko DR, Peskind E, Clark CM et al (2012) Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Arch Neurol 69(7):836\u2013841","DOI":"10.1001\/archneurol.2012.85"},{"issue":"11","key":"1065_CR18","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/01.jnen.0000240468.12543.af","volume":"65","author":"M Garcia-Alloza","year":"2006","unstructured":"Garcia-Alloza M, Dodwell SA, Meyer-Luehmann M et al (2006) Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model. J Neuropathol Exp Neurol 65(11):1082\u20131089","journal-title":"J Neuropathol Exp Neurol"},{"issue":"11","key":"1065_CR19","first-page":"1082","volume":"65","author":"T Gomez-Isla","year":"1997","unstructured":"Gomez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, Parisi JE, Hyman BT (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer\u2019s disease. J Neuropathol Exp Neurol 65(11):1082\u20131089","journal-title":"J Neuropathol Exp Neurol"},{"issue":"14","key":"1065_CR20","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1523\/JNEUROSCI.16-14-04491.1996","volume":"16","author":"T Gomez-Isla","year":"1996","unstructured":"Gomez-Isla T, Price JL, McKeel DW et al (1996) Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer\u2019s disease. J Neurosci 16(14):4491\u20134500","journal-title":"J Neurosci"},{"issue":"13","key":"1065_CR21","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1073\/pnas.1115402109","volume":"109","author":"S Guareschi","year":"2012","unstructured":"Guareschi S, Cova E, Cereda C et al (2012) An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1. Proc Natl Acad Sci USA 109(13):5074\u20135079","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"1065_CR22","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/emmm.201200243","volume":"4","author":"FX Guix","year":"2012","unstructured":"Guix FX, Wahle T, Vennekens K et al (2012) Modification of gamma-secretase by nitrosative stress links neuronal aging to sporadic Alzheimer\u2019s disease. EMBO Mol Med 4(7):660\u2013673","journal-title":"EMBO Mol Med"},{"key":"1065_CR23","doi-asserted-by":"crossref","unstructured":"Gwon AR, Park JS, Arumugam TV et al. (2012) Oxidative lipid modification of nicastrin enhances amyloidogenic gamma-secretase activity in Alzheimer\u2019s disease. Aging Cell 11(4):559\u2013568","DOI":"10.1111\/j.1474-9726.2012.00817.x"},{"issue":"4","key":"1065_CR24","first-page":"559","volume":"11","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Aging Cell 11(4):559\u2013568","journal-title":"Aging Cell"},{"issue":"5284","key":"1065_CR25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"K Hsiao","year":"1996","unstructured":"Hsiao K, Chapman P, Nilsen S et al (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274(5284):99\u2013102","journal-title":"Science"},{"issue":"8","key":"1065_CR26","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/archneurol.2011.70","volume":"68","author":"BT Hyman","year":"2011","unstructured":"Hyman BT (2011) Amyloid-dependent and amyloid-independent stages of Alzheimer disease. Arch Neurol 68(8):1062\u20131064","journal-title":"Arch Neurol"},{"issue":"6","key":"1065_CR27","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1212\/01.WNL.0000115115.98960.37","volume":"62","author":"M Ingelsson","year":"2004","unstructured":"Ingelsson M, Fukumoto H, Newell KL et al (2004) Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 62(6):925\u2013931","journal-title":"Neurology"},{"issue":"17","key":"1065_CR28","doi-asserted-by":"crossref","first-page":"12388","DOI":"10.1074\/jbc.M611549200","volume":"282","author":"N Isoo","year":"2007","unstructured":"Isoo N, Sato C, Miyashita H et al (2007) Abeta42 overproduction associated with structural changes in the catalytic pore of gamma-secretase: common effects of Pen-2 N-terminal elongation and fenofibrate. J Biol Chem 282(17):12388\u201312396","journal-title":"J Biol Chem"},{"issue":"Pt 5","key":"1065_CR29","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/awp062","volume":"132","author":"CR Jack Jr","year":"2009","unstructured":"Jack CR Jr, Lowe VJ, Weigand SD et al (2009) Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer\u2019s disease: implications for sequence of pathological events in Alzheimer\u2019s disease. Brain 132(Pt 5):1355\u20131365","journal-title":"Brain"},{"issue":"1","key":"1065_CR30","doi-asserted-by":"crossref","first-page":"014008","DOI":"10.1117\/1.2837169","volume":"13","author":"PB Jones","year":"2008","unstructured":"Jones PB, Rozkalne A, Meyer-Luehmann M et al (2008) Two postprocessing techniques for the elimination of background autofluorescence for fluorescence lifetime imaging microscopy. J Biomed Opt 13(1):014008","journal-title":"J Biomed Opt"},{"issue":"1","key":"1065_CR31","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ana.21426","volume":"64","author":"KA Josephs","year":"2008","unstructured":"Josephs KA (2008) Frontotemporal dementia and related disorders: deciphering the enigma. Ann Neurol 64(1):4\u201314","journal-title":"Ann Neurol"},{"key":"1065_CR32","author":"N Kakuda","year":"2012","unstructured":"Kakuda N, Akazawa K, Hatsuta H et al (2012) Suspected limited efficacy of gamma-secretase modulators. Neurobiol Aging. doi: 10.1016\/j.neurobiolaging.2012.08.017","journal-title":"Neurobiol Aging"},{"issue":"2","key":"1065_CR33","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1523\/JNEUROSCI.21-02-00372.2001","volume":"21","author":"T Kawarabayashi","year":"2001","unstructured":"Kawarabayashi T, Younkin LH, Saido TC et al (2001) Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer\u2019s disease. J Neurosci 21(2):372\u2013381","journal-title":"J Neurosci"},{"issue":"Pt 9","key":"1065_CR34","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/brain\/awh598","volume":"128","author":"A Kertesz","year":"2005","unstructured":"Kertesz A, McMonagle P, Blair M et al (2005) The evolution and pathology of frontotemporal dementia. Brain 128(Pt 9):1996\u20132005","journal-title":"Brain"},{"issue":"10","key":"1065_CR35","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1073\/pnas.0811698106","volume":"106","author":"RM Koffie","year":"2009","unstructured":"Koffie RM, Meyer-Luehmann M, Hashimoto T et al (2009) Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci USA 106(10):4012\u20134017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"1065_CR36","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neuron.2008.06.008","volume":"59","author":"KV Kuchibhotla","year":"2008","unstructured":"Kuchibhotla KV, Goldman ST, Lattarulo CR et al (2008) Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 59(2):214\u2013225","journal-title":"Neuron"},{"issue":"19","key":"1065_CR37","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1038\/emboj.2010.211","volume":"29","author":"I Kuperstein","year":"2010","unstructured":"Kuperstein I, Broersen K, Benilova I et al (2010) Neurotoxicity of Alzheimer\u2019s disease Abeta peptides is induced by small changes in the Abeta42 to Abeta40 ratio. EMBO J 29(19):3408\u20133420","journal-title":"EMBO J"},{"key":"1065_CR38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-1-4613-9359-7_3","volume":"13","author":"JR Lakowicz","year":"1988","unstructured":"Lakowicz JR (1988) Principles of frequency-domain fluorescence spectroscopy and applications to cell membranes. Sub-cellular Biochem 13:89\u2013126","journal-title":"Sub-cellular Biochem"},{"issue":"2","key":"1065_CR39","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0003-2697(92)90112-K","volume":"202","author":"JR Lakowicz","year":"1992","unstructured":"Lakowicz JR, Szmacinski H, Nowaczyk K et al (1992) Fluorescence lifetime imaging. Anal Biochem 202(2):316\u2013330","journal-title":"Anal Biochem"},{"issue":"7082","key":"1065_CR40","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","volume":"440","author":"S Lesne","year":"2006","unstructured":"Lesne S, Koh MT, Kotilinek L et al (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440(7082):352\u2013357","journal-title":"Nature"},{"issue":"3","key":"1065_CR41","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0197-4580(03)00086-1","volume":"25","author":"P Lewczuk","year":"2004","unstructured":"Lewczuk P, Esselmann H, Otto M et al (2004) Neurochemical diagnosis of Alzheimer\u2019s dementia by CSF Abeta42, Abeta42\/Abeta40 ratio and total tau. Neurobiol Aging 25(3):273\u2013281","journal-title":"Neurobiol Aging"},{"issue":"10","key":"1065_CR42","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm1112","volume":"10","author":"A Lleo","year":"2004","unstructured":"Lleo A, Berezovska O, Herl L et al (2004) Nonsteroidal anti-inflammatory drugs lower Abeta42 and change presenilin 1 conformation. Nature Med 10(10):1065\u20131066","journal-title":"Nature Med"},{"issue":"14","key":"1065_CR43","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1002\/jnr.21346","volume":"85","author":"MA Lovell","year":"2007","unstructured":"Lovell MA, Markesbery WR (2007) Oxidative damage in mild cognitive impairment and early Alzheimer\u2019s disease. J Neurosci Res 85(14):3036\u20133040","journal-title":"J Neurosci Res"},{"issue":"1","key":"1065_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-009-0612-2","volume":"119","author":"IR Mackenzie","year":"2010","unstructured":"Mackenzie IR, Neumann M, Bigio EH et al (2010) Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 119(1):1\u20134","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1065_CR45","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1212\/WNL.43.1_Part_1.192","volume":"43","author":"E Masliah","year":"1993","unstructured":"Masliah E, Mallory M, Hansen L et al (1993) Quantitative synaptic alterations in the human neocortex during normal aging. Neurology 43(1):192\u2013197","journal-title":"Neurology"},{"issue":"7","key":"1065_CR46","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M et al (1984) Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s disease. Neurology 34(7):939\u2013944","journal-title":"Neurology"},{"issue":"11","key":"1065_CR47","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1001\/archneur.58.11.1803","volume":"58","author":"GM McKhann","year":"2001","unstructured":"McKhann GM, Albert MS, Grossman M et al (2001) Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on frontotemporal dementia and Pick\u2019s disease. Archives Neurol 58(11):1803\u20131809","journal-title":"Archives Neurol"},{"issue":"3","key":"1065_CR48","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s Dement 7(3):263\u2013269","journal-title":"Alzheimer\u2019s Dement"},{"issue":"6","key":"1065_CR49","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1523\/JNEUROSCI.23-06-02212.2003","volume":"23","author":"ME McLellan","year":"2003","unstructured":"McLellan ME, Kajdasz ST, Hyman BT, Bacskai BJ (2003) In vivo imaging of reactive oxygen species specifically associated with thioflavine S-positive amyloid plaques by multiphoton microscopy. J Neurosci 23(6):2212\u20132217","journal-title":"J Neurosci"},{"issue":"3","key":"1065_CR50","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/jnr.10355","volume":"70","author":"M Morishima-Kawashima","year":"2002","unstructured":"Morishima-Kawashima M, Ihara Y (2002) Alzheimer\u2019s disease: beta-Amyloid protein and tau. J Neurosci Res 70(3):392\u2013401","journal-title":"J Neurosci Res"},{"issue":"4 Suppl","key":"1065_CR51","first-page":"S1","volume":"18","author":"NIA-RI","year":"1997","unstructured":"NIA-RI (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer\u2019s disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer\u2019s Disease. Neurobiol Aging 18(4 Suppl):S1\u2013S2","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1065_CR52","doi-asserted-by":"crossref","first-page":"e5088","DOI":"10.1371\/journal.pone.0005088","volume":"4","author":"L Placanica","year":"2009","unstructured":"Placanica L, Zhu L, Li YM (2009) Gender- and age-dependent gamma-secretase activity in mouse brain and its implication in sporadic Alzheimer disease. PLoS One 4(4):e5088","journal-title":"PLoS One"},{"issue":"12","key":"1065_CR53","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1523\/JNEUROSCI.21-12-04183.2001","volume":"21","author":"D Pratico","year":"2001","unstructured":"Pratico D, Uryu K, Leight S et al (2001) Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 21(12):4183\u20134187","journal-title":"J Neurosci"},{"issue":"4","key":"1065_CR54","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s11065-009-9118-x","volume":"19","author":"KM Rodrigue","year":"2009","unstructured":"Rodrigue KM, Kennedy KM, Park DC (2009) Beta-amyloid deposition and the aging brain. Neuropsychol Rev 19(4):436\u2013450","journal-title":"Neuropsychol Rev"},{"issue":"8","key":"1065_CR55","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nn.2858","volume":"14","author":"T Saito","year":"2011","unstructured":"Saito T, Suemoto T, Brouwers N et al (2011) Potent amyloidogenicity and pathogenicity of Abeta43. Nat Neurosci 14(8):1023\u20131032","journal-title":"Nat Neurosci"},{"issue":"17","key":"1065_CR56","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJM199704243361704","volume":"336","author":"M Sano","year":"1997","unstructured":"Sano M, Ernesto C, Thomas RG et al (1997) A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer\u2019s disease. The Alzheimer\u2019s disease Cooperative Study. NE J Med 336(17):1216\u20131222","journal-title":"NE J Med"},{"issue":"3","key":"1065_CR57","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.nbd.2004.10.022","volume":"18","author":"A Savonenko","year":"2005","unstructured":"Savonenko A, Xu GM, Melnikova T et al (2005) Episodic-like memory deficits in the APPswe\/PS1dE9 mouse model of Alzheimer\u2019s disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities. Neurobiol Dis 18(3):602\u2013617","journal-title":"Neurobiol Dis"},{"issue":"5","key":"1065_CR58","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1046\/j.1471-4159.1997.68052092.x","volume":"68","author":"LM Sayre","year":"1997","unstructured":"Sayre LM, Zelasko DA, Harris PL et al (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer\u2019s disease. J Neurochem 68(5):2092\u20132097","journal-title":"J Neurochem"},{"issue":"8","key":"1065_CR59","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","volume":"2","author":"D Scheuner","year":"1996","unstructured":"Scheuner D, Eckman C, Jensen M et al (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer\u2019s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer\u2019s disease. Nature Med 2(8):864\u2013870","journal-title":"Nature Med"},{"issue":"2","key":"1065_CR60","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","volume":"81","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe DJ (2001) Alzheimer\u2019s disease: genes, proteins, and therapy. Physiol Rev 81(2):741\u2013766","journal-title":"Physiol Rev"},{"issue":"5927","key":"1065_CR61","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1126\/science.1171176","volume":"324","author":"L Serneels","year":"2009","unstructured":"Serneels L, Van Biervliet J, Craessaerts K et al (2009) gamma-Secretase heterogeneity in the Aph1 subunit: relevance for Alzheimer\u2019s disease. Science 324(5927):639\u2013642","journal-title":"Science"},{"issue":"3","key":"1065_CR62","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.ajpath.2011.05.047","volume":"179","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Mielke ML, Gomez-Isla T et al (2011) Reactive glia not only associates with plaques but also parallels tangles in Alzheimer\u2019s disease. Amer J Pathol 179(3):1373\u20131384","journal-title":"Amer J Pathol"},{"issue":"1","key":"1065_CR63","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3233\/JAD-2010-1222","volume":"19","author":"R Sultana","year":"2010","unstructured":"Sultana R, Butterfield DA (2010) Role of oxidative stress in the progression of Alzheimer\u2019s disease. J Alzheimer\u2019s Dis: JAD 19(1):341\u2013353","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"issue":"4","key":"1065_CR64","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD, Masliah E, Salmon DP et al (1991) Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30(4):572\u2013580","journal-title":"Ann Neurol"},{"issue":"3","key":"1065_CR65","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ceca.2011.02.001","volume":"49","author":"L Texido","year":"2011","unstructured":"Texido L, Martin-Satue M, Alberdi E et al (2011) Amyloid beta peptide oligomers directly activate NMDA receptors. Cell Calcium 49(3):184\u2013190","journal-title":"Cell Calcium"},{"issue":"1","key":"1065_CR66","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80291-3","volume":"17","author":"G Thinakaran","year":"1996","unstructured":"Thinakaran G, Borchelt DR, Lee MK et al (1996) Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17(1):181\u2013190","journal-title":"Neuron"},{"issue":"1","key":"1065_CR67","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1750-1326-6-15","volume":"6","author":"K Uemura","year":"2011","unstructured":"Uemura K, Farner KC, Nasser-Ghodsi N et al (2011) Reciprocal relationship between APP positioning relative to the membrane and PS1 conformation. Mol Neurodegener 6(1):15","journal-title":"Mol Neurodegener"},{"issue":"11","key":"1065_CR68","doi-asserted-by":"crossref","first-page":"e7893","DOI":"10.1371\/journal.pone.0007893","volume":"4","author":"K Uemura","year":"2009","unstructured":"Uemura K, Lill CM, Li X, Peters JA et al (2009) Allosteric modulation of PS1\/gamma-secretase conformation correlates with amyloid beta (42\/40) ratio. PLoS One 4(11):e7893","journal-title":"PLoS One"},{"issue":"8","key":"1065_CR69","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.neurobiolaging.2005.06.004","volume":"27","author":"TI Williams","year":"2006","unstructured":"Williams TI, Lynn BC, Markesbery WR, Lovell MA (2006) Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer\u2019s disease. Neurobiol Aging 27(8):1094\u20131099","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1065_CR70","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1471-4159.2006.04404.x","volume":"101","author":"J Wiltfang","year":"2007","unstructured":"Wiltfang J, Esselmann H, Bibl M et al (2007) Amyloid beta peptide ratio 42\/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load. J Neurochem 101(4):1053\u20131059","journal-title":"J Neurochem"},{"issue":"2","key":"1065_CR71","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/sj.embor.7400896","volume":"8","author":"MS Wolfe","year":"2007","unstructured":"Wolfe MS (2007) When loss is gain: reduced presenilin proteolytic function leads to increased Abeta42\/Abeta40. Talking Point on the role of presenilin mutations in Alzheimer disease. EMBO Rep 8(2):136\u2013140","journal-title":"EMBO Rep"},{"issue":"6727","key":"1065_CR72","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/19077","volume":"398","author":"MS Wolfe","year":"1999","unstructured":"Wolfe MS, Xia W, Ostaszewski BL, Diehl TS et al (1999) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398(6727):513\u2013517","journal-title":"Nature"},{"issue":"4","key":"1065_CR73","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/emmm.200900026","volume":"1","author":"K Yanagida","year":"2009","unstructured":"Yanagida K, Okochi M, Tagami S et al (2009) The 28-amino acid form of an APLP1-derived Abeta-like peptide is a surrogate marker for Abeta42 production in the central nervous system. EMBO Mol Med 1(4):223\u2013235","journal-title":"EMBO Mol Med"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-012-1065-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-012-1065-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-012-1065-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T07:05:47Z","timestamp":1562310347000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-012-1065-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,9]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["1065"],"URL":"https:\/\/doi.org\/10.1007\/s00401-012-1065-6","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,9]]}}}